Bruker sees Q4 2024 revenue of $970M-$980M; 2025 outlook of upper mid-single digit growth

BRUKER CORP

2024-FY EPS reported $0.76 revenue$3,366,400,000

Preliminary Q4 2024 revenue guidance of $970M to $980M (unaudited, subject to change).
BSI segment bookings described as solid in the fourth quarter.
2025 constant exchange rate revenue growth outlook: upper mid-single digits, assuming low-single digit market growth.
Company presented at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.
Final Q4 and full-year 2024 financial statements have not yet been completed or audited.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.